| Literature DB >> 35959252 |
Ali Farhanghi1, Javad Aliakbarlu1, Hossein Tajik1, Negar Mortazavi1, Leila Manafi1, Ghader Jalilzadeh-Amin2.
Abstract
The aim of this study was to investigate the antibacterial interactions of pulegone and 1,8-cineole with monolaurin ornisin against Staphylococcus aureus. The individual and combined antibacterial activities of the compounds were evaluated using minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), fractional inhibitory concentration index (FICi), and time-kill methods. Furthermore, the mechanism of the antibacterial action of the compounds was tested by measuring the release of cell constituents. The MIC values of pulegone, 1,8-cineole, nisin, and monolaurin were 5.85 µl/ml, 23.43 µl/ml, 6.25 µg/ml, and 0.031 mg/ml, respectively. A synergistic antibacterial activity (FICi = 0.5) was found between 1,8-cineole and nisin. The time-kill assay showed that the populations of S. aureus exposed to 1,8-cineole, nisin, and their combination were decreased by 5.9, 5.3, and 7.1 log CFU (colony-forming units)/mL, respectively. The combination of 1,8-cineole and nisin also induced the highest release of cell constituents. It was concluded that the combination of 1,8-cineole and nisin could be considered as a novel and promising combination which may reduce the required dose of each antibacterial compound.Entities:
Keywords: 1,8‐cineole; S. aureus; combination; monolaurin; nisin; pulegone
Year: 2022 PMID: 35959252 PMCID: PMC9361456 DOI: 10.1002/fsn3.2870
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 3.553
The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of pulegone, 1,8‐cineol (µl/ml), monolaurin (mg/ml), and nisin (µg/mL) against Staphylococcus aureus
| Antimicrobial | MIC | MBC |
|---|---|---|
| Pulegone | 5.85 | 11.71 |
| 1,8‐Cineol | 23.43 | 23.43 |
| Monolaurin | 0.031 | 0.031 |
| Nisin | 6.25 | 6.25 |
| Erythromycin | 8 | 8 |
µg/ml.
The fractional inhibitory concentration index (FICi) of the antimicrobials against Staphylococcus aureus
| Antimicrobial combination | FIC | FICi | Function |
|---|---|---|---|
| Pulegone | 0.25 | 0.75 | Partial synergistic |
| Monolaurin | 0.5 | ||
| Pulegone | 1 | 1.5 | Indifferent |
| Nisin | 0.5 | ||
| 1,8‐Cineol | 1 | 1.122 | Indifferent |
| Monolaurin | 0.122 | ||
| 1,8‐Cineol | 0.25 | 0.5 | Synergistic |
| Nisin | 0.25 |
FIGURE 1The antibacterial effects of pulegone, monolaurin, and their combination against Staphylococcus aureus (log CFU/ml) during 24 h incubation at 37°C. P: pulegone; ML: monolaurin
FIGURE 2The antibacterial effects of pulegone, nisin, and their combination against Staphylococcus aureus (log CFU/ml) during 24 h incubation at 37°C. P: pulegone; N: nisin
FIGURE 3The antibacterial effects of 1,8‐cineol, monolaurin, and their combination against Staphylococcus aureus (log CFU/ml) during 24 h incubation at 37°C. C: 1,8‐cineol; ML: monolaurin
FIGURE 4The antibacterial effects of 1,8cineol, nisin, and their combination against Staphylococcus aureus (log CFU/ml) during 24 h incubation at 37°C. C: 1,8‐cineol; N: Nisin
The cell constituents’ release in Staphylococcus aureus induced by individual (at 2 × MIC (minimum inhibitory concentration)) and combined antimicrobials (at MIC of each antimicrobial)
| Antimicrobial treatments | ODa | ODb | ODa–ODb |
|---|---|---|---|
| Control | 0.165 ± 0.014 | – | 0.165 ± 0.014 |
| Pulegone | 3≤ | 2.140 | – |
| 1,8‐Cineol | 1.690 ± 0.018 | 1.100 | 0.590 ± 0.018 |
| Monolaurin | 0.368 ± 0.011 | 0.022 | 0.346 ± 0.011 |
| Nisin | 0.611 ± 0.031 | 0.156 | 0.455 ± 0.031 |
| Pulegone + Monolaurin | 3≤ | 1.938 | – |
| Pulegone + Nisin | 3≤ | 2.112 | – |
| 1,8‐Cineol + Monolaurin | 1.710 ± 0.024 | 0.850 | 0.860 ± 0.024 |
| 1,8‐Cineol + Nisin | 1.971 ± 0.016 | 0.740 | 1.231 ± 0.016 |
ODa = optical density of PBS + antimicrobial + bacterial suspension.
ODb = optical density of PBS + antimicrobial.